The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments.
Read more: New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
Read more: New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound